Navana Pharmaceuticals PLC (DSE:NAVANAPHAR)
70.50
-1.40 (-1.95%)
At close: Jun 16, 2026
39.33% (1Y)
| Market Cap | 7.57B +34.5% |
| Revenue (ttm) | 10.57B +24.8% |
| Net Income | 606.13M +35.3% |
| EPS | 5.60 +34.4% |
| Shares Out | 107.42M |
| PE Ratio | 12.58 |
| Forward PE | n/a |
| Dividend | 1.40 (1.95%) |
| Ex-Dividend Date | Nov 20, 2025 |
| Volume | 516,324 |
| Open | 71.80 |
| Previous Close | 71.90 |
| Day's Range | 70.30 - 72.00 |
| 52-Week Range | 45.50 - 78.00 |
| Beta | 0.20 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jun 3, 2026 |